Drug Profile
Rifapentine - Sanofi
Alternative Names: DL 473; L 11473; M000473; MDL 473; Priftin; R 773Latest Information Update: 22 Dec 2023
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Developer Centers for Disease Control and Prevention; Sanofi; sanofi-aventis
- Class Antituberculars; Heterocyclic compounds; Piperazines; Rifamycins
- Mechanism of Action DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Tuberculosis
- No development reported Mycobacterium avium complex infections